UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA begins to review Samsung Bioepis' anticancer biosimilar application
by Lee Han-soo
2019-11-20 15:10
Vivozon’s acquisition of Lumimicro may aim at backdoor listing
by Jeong Sae-im
2019-11-20 14:44
ABL Bio, Genscript to cooperate on bispecific antibodies
by Lee Han-soo
2019-11-19 17:18
Will Biogen be 1st to get FDA nod for Alzheimer’s drug?
by Kim Yun-mi
2019-11-14 11:23
How can Korean drugmakers enter Europe successfully?
by Jeong Sae-im
2019-11-13 15:22
라인
Samsung Bioepis expects ₩1 trillion biosimilar sales this year
by Jeong Sae-im
2019-11-13 15:21
[News Focus] ‘FDA could allow resumption of Invossa trial’
by Jeong Sae-im
2019-11-12 15:48
Celltrion marks robust Q3 sales
by Lee Han-soo
2019-11-07 14:03
Samsung Bioepis, Biogen to commercialize next-generation biosimilar candidates
by Lee Han-soo
2019-11-07 11:16
Court rejects arrest warrant for 2 Kolon execs
by Jeong Sae-im
2019-11-05 13:54
라인
Samsung BioLogics to make Ichnos Sciences’ atopic dermatitis treatment
by Lee Han-soo
2019-11-05 12:47
Prosecutors seek to arrest 2 Kolon execs for false Invossa data
by Jeong Sae-im
2019-10-31 15:34
Syntekabio passes prior review for Kosdaq listing
by Jeong Sae-im
2019-10-31 13:27
Prosecution seeks jail term for Samsung execs for destroying evidence
by Jeong Sae-im
2019-10-29 13:10
KangStem Biotech changes strategy for atopic dermatitis drug
by Jeong Sae-im
2019-10-28 15:34
라인
Bridge Biotherapeutics passes preliminary review for Kosdaq listing
by Jeong Sae-im
2019-10-25 15:05
Celltrion launches Herzuma in Brazil
by Lee Han-soo
2019-10-25 13:56
KangStem Biotech fails in phase-3 study on atopic dermatitis drug
by Jeong Sae-im
2019-10-25 11:17
Samsung Bioepis' biosimilar sales in EU top $180 million in Q3
by Lee Han-soo
2019-10-23 17:43
Medipost wins patent for mesenchymal stem cell culture in China
by Lee Han-soo
2019-10-23 16:30
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top